EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Denis Chem Lab's enterprise value is ₹2,224 Mil.
Denis Chem Lab's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹217 Mil. Therefore, Denis Chem Lab's EV-to-EBITDA for today is 10.25.
The historical rank and industry rank for Denis Chem Lab's EV-to-EBITDA or its related term are showing as below:
BOM:537536'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.1 Med: 7.01 Max: 19.34
Current: 10.25
During the past 11 years, the highest EV-to-EBITDA of Denis Chem Lab was 19.34. The lowest was 1.10. And the median was 7.01.
BOM:537536's EV-to-EBITDA is ranked better than 64.66% of 713
companies
in the Drug Manufacturers industry
Industry Median: 14.45
vs BOM:537536: 10.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Denis Chem Lab EV-to-EBITDA Historical Data
The historical data trend for Denis Chem Lab's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Denis Chem Lab's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Denis Chem Lab's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Denis Chem Lab's EV-to-EBITDA falls into.
Denis Chem Lab EV-to-EBITDA Calculation
Denis Chem Lab's EV-to-EBITDA for today is calculated as:
Denis Chem Lab's current Enterprise Value is ₹2,224 Mil.
Denis Chem Lab's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹217 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Denis Chem Lab's PE Ratio for today is calculated as:
Denis Chem Lab's share price for today is ₹178.15.
Denis Chem Lab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6.620.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Denis Chem Lab's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:537536 has been successfully added to your 